15^th International Conference on Tissue Science and Regenerative Medicine May 15-16, 2023 Prague, Czech Republic

Dr. Allen-Hoffmann is the Founder, CEO, Chief Science Officer and a Director of Stratatech. Dr. Allen-Hoffmann obtained her doctorate from Cornell University and trained with Dr. James Rheinwald at Harvard Medical School. Dr. Allen-Hoffmann has been Professor of Pathology at the University of Wisconsin Medical School since 1988 and has received continuous funding from the National Institutes of Health for her research program. She has extensive leadership experience and previously directed a multi-college Center at the University of Wisconsin-Madison. Recently Dr. Allen-Hoffmann’s research and business contributions have been recognized by the 2005 Harold Rusch Translational Research Award and 2006 TEMPO Business Women of Distinction.

Dr. Allen-Hoffmann’s research interest focus on keratinocytes; cancer biology; extracellular matrices, bioengineered human skin Tissue, wound healing.

Dr. Alex Chen is the director of VA Vascular Surgery Research, VA Pittsburgh Healthcare System, at the University of Pittsburgh School of Medicine. He is also professor of surgery. Prior to this he was an assistant professor in the Department of Pharmacology and Toxicology at Michigan State University College of Medicine. Dr. Chen got his medical degree from Hunan Medical University in China. From there he moved to Southern Illinois University, where he earned his MS and PhD in Pharmacology. He then became a NIH Postdoctoral Fellow at the Mayo Clinic in Rochester, Minnesota, where he focused on anesthesiology. Dr. Chen is the editor-in-chief of Frontiers in Integrative and Regenerative Pharmacology, and he is on the editorial board of several journals, including Open Hypertension Journal, American Journal of Physiology (Heart & Circ Physiology), and Advances in Pharmacological Sciences.

Dr. Chen's research focuses on vascular biology and disease, with an ultimate goal of translating mechanistic insights gained for new therapeutic modalities including cell therapies.

Dr. Ian McNiece obtained his PhD from Melbourne University, Australia in 1986 and his thesis work was undertaken at the Peter MacCallum Cancer Institute. He did a post doctoral fellowship with Dr Peter Quesenberry in Charlottesville, Virginia and then worked at Amgen Inc, in California for 9 years studying hematopoietic growth factors. Dr McNiece returned to academia in 1997 and worked at the University of Colorado in Denver as the Director of Research in the Bone Marrow Transplant Program. In 2003 he moved to Baltimore as Professor of Oncology at Johns Hopkins University, where he served as Director and CEO of the Division of Biomedical Sciences Johns Hopkins Singapore and Director of the Stem Cell Therapy clinical laboratory. In 2007 he moved to Miami as Professor of Medicine in the Interdisciplinary Stem Cell Institute at the University of Miami, and Director of the Experimental and Clinical Cell Based Therapies Program which supports translational clinical research in cellular therapy. He is currently the Director of the Stem Cell Transplantation and Cellular Therapy Clinical Laboratories at MD Anderson Cancer Center in Houston, Tx. His work has focused on translational medicine with approaches using stem cells and the generation of cellular products for therapeutic treatments.

Dr. Ian McNiece research focuses on translational medicine, stem cells and the generation of cellular products for therapeutic treatments.

Dr. Ernst J. Reichenberger is an Associate Professor in the Department of Reconstructive Sciences and a founding member of the Center for Regenerative Medicine and Skeletal Development in the School of Dental Medicine at the University of Connecticut Health Center (UCHC). Dr. Reichenberger has obtained his doctoral degree in the field of Molecular Biology of Connective Tissue from University of Erlangen, Max-Planck-Group for Rheumatology. Dr. Reichenberger has obtained his master's degree in Botany and Biochemistry from University of Erlangen, Germany. Dr. Reichenberger acted as member of several professional societies.

The interest of Dr. Ernst J. Reichenberger laboratory is the genetic origin of human bone and skin/wound healing diseases with a major focus on research of keloids and rare skeletal disorders. My laboratory has extensive experience with disease gene identification and mutation analysis. For disorders where we identified the genetic origin we created animal models to study the function of the mutant genes. In continuation of those projects we are now using animal models, in vitro models and iPS cell approaches to study mutational effects in the human system.

Dr. Marlene Shehata has received her PhD in Cellular and Molecular Medicine, specializing in Genetics of Cardiovascular Diseases from the University of Ottawa during the period of 2004-2010. Dr. Shehata is also a licensed Ontario Pharmacist practicing in Southwestern Ontario. Currently, she is working as a Clinical Pharmacist Consultant in numerous academic hospitals, nursing homes and community pharmacies in Southwestern Ontario.

Dr. Marlene Shehata's research focuses on targeting the salt-sensitive high blood pressure. This particular kind of high blood pressure has been connected with a genetic component that is inherited from parents to offspring and that is usually exacerbated by high salt-intake. As a Geneticist Candidate and a Pharmacist, Dr. Marlene is investigating the genes that might be involved in transmitting that genetic form of high blood pressure.

Dr. Abidian directs the laboratory Advanced Regenerative Biomaterials and Therapeutics for Neural Interfaces, which investigates development of innovative organic bioelectronics for neural interface applications. His lab utilizes interdisciplinary approaches for development of low-cost and high-throughput neural interface technologies for regenerative neural engineering, diagnosis, and treatment of neurological disorders and diseases with an emphasis on translational neural engineering. Current efforts in his lab is focused on neural recording and stimulation, neural tissue regeneration, drug delivery to brain tumor, and neurochemical sensing.

Mohammad Reza Abidian research focuses on Multifunctional organic-inorganic hybrid nanobiomaterials for smart targeted drug delivery to brain tumors; Bioactive conducting polymer and carbon nanotubes for axonal regeneration and biotic-abiotic interface of neural prostheses; Chronic, selective, and sensitive detection of neurochemicals using conducting polymer micro/nano-tubes. Dr. Abidian�s research is focused on developing neural devices with applications in diagnosis and treatment of neural diseases or disorders and brain tumors. His research has been funded by the NIH and NSF. Dr. Abidian�s research has featured several times on the cover of frontier journals including Advanced Materials and Advanced Functional Materials, and Advanced Healthcare Materials.

Professor Wan-Ju Li is the Principal Investigator of the Musculoskeletal Biology and Regenerative Medicine Laboratory at the University of Wisconsin-Madison in the United States of America. He is also an affiliated faculty member in Cellular and Molecular Biology Program, and Stem Cell and Regenerative Medicine Center. His research interests include stem cell, tissue engineering, nanobiomaterial, and skeletal biology. Professor Li is the member of International Society for Stem Cell Research, Orthopaedic Research Society, Tissue Engineering International and Regenerative Medicine Society, American Society for Cell Biology, and American Society for Bone and Mineral Research. Professor Li has published 30 papers, 9 book chapters, and more than 60 abstracts. He holds 3 patents in cartilage, intervertebral disc, and tendon/ligament applications. Professor Li has received Fellow Award for Research Excellence from National Institutes of Health, and Young Investigator Research Award from North American Spine Society. He also serves in the editorial board of American Journal of Stem Cells, Journal of Regenerative Medicine and Tissue Engineering, Formosan Journal of Musculoskeletal Disorders, and Journal of Biosensors and Bioelectronics.

Professor Li's research interests include stem cell, tissue engineering, nanobiomaterial, and skeletal biology.

Dr. Medet Jumabay has graduated from medical school and started her medical career at the Emergency Center of the First Affiliated Hospital of Xinjiang Medical University. Later she became an attendant physician and cardiologist in the department of medicine at the same university. Dr. Medet Jumabay received her Master’s degree from the Xinjiang Medical University and a PhD. degree from the Department of Medicine, Nihon University, Tokyo, Japan in medical science. Dr. Medet Jumabay first became fascinated by the power of cell plasticity when she saw beating cardiomyocytes, which are derived from adipose stem cells. Thus, she became interested in cell regeneration research immediately after completing her PhD. studies. In 2007, she was recruited to the Division of Cardiology, Department of Medicine, UCLA, as a researcher in the field of cardiovascular and stem cell biology.

Dr. Jumabay's research concentrated on the isolation of stem cells from adipose tissue and the generation of dedifferentiated fat cells (DFAT), white mature adipocyte derived stem cells and tissue regeneration.

Dr. Shohta Kodama is currently an Associate Professor, Department of Regenerative Medicine & Transplantation, Faculty of Medicine, Fukuoka University. Dr. Kodama has obtained his PhD from Graduate School of Fukuoka University, Fukuoka, Japan. Dr. Kodama is a Member of the Tissue Engineering and Regenerative Medicine International Society (TERMIS) and a council of the Japanese Society for Regenerative Medicine, American Society of Transplantation Surgeon (ASTS) /A member of Program committee. Dr. Kodama is also a Regular Member in The Transplantation Society (TTS), International Pancreas and Islet Transplant Association (IPITA), Federation of American Society for Experimental Biology (FASEB), The American Association of Immunologist (AAI), Japan Surgical Society and Japanese Society of Gastroenterological Surgery. Dr. Kodama is serving as the Editorial Board Member in "Islets" and "The American Journal of Medical and Biological Research". Dr. Kodama has authored many paper publications.

Dr. Kodama's reserch focuses on Regenerative Medicine, Stem Cell Research, Transplantation Immunology, Islet Cell Biology.

Dr. Youngsook Lee is an Associate Professor in the Department of Cell and Regenerative Biology at the University of Wisconsin-Madison, USA. Dr. Lee has completed her B.S, from Ewha Women's University, Seoul, Korea; M.S from Seoul National University, Seoul, Korea. Dr. Lee has obtained her Ph.D from the University of Wisconsin, Madison and did Postdoctoral Research in Harvard Medical School, Boston.

Dr. Youngsook Lee's research focuses on Transcriptional control of normal cardiovascular development and function.